Michael Gilvarry

General Manager, CERENOVUS Neuro Technology Center

Michael leads the acute ischemic stroke R&D portfolio as General Manager of the CERENOVUS Neuro Technology Centre (Galway Ireland). Prior to the Johnson & Johnson acquisition of Neuravi, Michael was Vice President of R&D and Technical Operations where he led the development and manufacture of the EMBOTRAP® II Revascularization Device. In Neuravi, he was the founder of the Neuro Thromboembolic Initiative (NTI) through which he led many international research projects in collaboration with Universities and Hospitals in the field of acute ischemic stroke. 

Michael has worked in the medical device industry for 20 years and is a named inventor on over 60 US patents, granted or pending. He holds a BSc in Mechanical Engineering and MSc in Engineering Science from NUI, Galway.


1 blog from the author

Fotolia_213241190_Subscription_Monthly_M (2)
In your head

Posted on 29.10.2018

World Stroke Day: Fighting the Battle Against Blood Clots

The stroke industry is united by a common goal, to develop effective solutions and provide access to treatment which prevents people dying or living a life of dependency because of stroke. World Stroke Day today is a pertinent reminder as to why we work tirelessly, to develop these solutions and deliver the right care so […]

By Michael Gilvarry General Manager, CERENOVUS Neuro Technology Center